Page 883 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 883

Benign and Premalignant Tumors 869
AB

 CD

Figure 23–22  Melanoma. A, On clinical evaluation, lesions tend to be larger than nevi, with irregular contours and pigmentation. Macular areas
indicate early superficial (radial) growth, while elevated areas often indicate dermal invasion (vertical growth). B, Radial growth phase, with spread of
nested and single-cell melanoma cells within the epidermis. C, Vertical growth phase, with nodular aggregates of infiltrating tumor cells within the
dermis (epidermis is on the right). D, Melanoma cells have hyperchromatic nuclei of irregular size and shape with prominent nucleoli. Mitoses, including
atypical forms such as seen in the center of this field, often are encountered. The inset shows a sentinel lymph node containing a tiny cluster of meta-
static melanoma cells (arrow), detected by staining for the melanocytic marker HMB-45.

melanoma have been seen, especially to antibodies that         •	 In most cases, melanoma progresses from an intraepithe-
block endogenous inhibitors of immune responses such as            lial (in situ) to an invasive (dermal) form. Characteristics
CTLA-4 and PD-1, and thus “release the brakes” on host             of the dermal tumor such as depth of invasion and mitotic
antitumor immunity.                                                activity correlate with survival.

   S U M M A RY                                                BIBLIOGRAPHY

Melanocytic Lesions, Benign and Malignant                      Curtin JA, Fridlyand J, Kageshita T, et al: Distinct sets of genetic altera-
                                                                  tions in melanoma. N Engl J Med 353:2135, 2005. [A modified classi-
•	 Most melanocytic nevi have activating mutations in BRAF or     fication of melanoma based on both clinical and genetic features. Such
    less often NRAS, but the vast majority never undergo          molecular classification schemes are critical for progress in targeted
    malignant transformation.                                     therapy.]

•	 Most sporadic dysplastic nevi are best regarded as markers  Elder DE: Dysplastic nevi: an update. Histopathology 56:112, 2010.
    of melanoma risk rather than premalignant lesions. They       [Balanced presentation of the histology and pathogenesis of dysplastic nevi
    are characterized by architectural and cytologic atypia.      and their relationship to melanoma.]

•	 Melanoma is a highly aggressive malignancy; tumors only a   Epstein EH: Basal cell carcinomas: attack of the hedgehog. Nat Rev
    few millimeters in thickness can give rise to deadly          Cancer 8:743, 2008. [Epidemiology, clinical presentation, molecular
    metastases.                                                   pathogenesis, and novel treatment options are succinctly reviewed.]
   878   879   880   881   882   883   884   885   886   887   888